Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)

ANNALS OF ONCOLOGY(2019)

引用 4|浏览28
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要